1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MSL1 CTRPv2 pan-cancer AAC 0.16 7e-07
mRNA NANS CTRPv2 pan-cancer AAC -0.17 7e-07
mRNA PLEKHG2 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA RP11-795F19.5 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA HMGB2 CTRPv2 pan-cancer AAC 0.2 7e-07
mRNA ANXA7 CTRPv2 pan-cancer AAC -0.17 8e-07
mRNA FOXJ3 CTRPv2 pan-cancer AAC 0.16 8e-07
mRNA MTG2 CTRPv2 pan-cancer AAC -0.16 8e-07
mRNA CRTC1 CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA UBTD1 CTRPv2 pan-cancer AAC -0.19 8e-07
Download CSV